Treatment with semaglutide demonstrated sustained, statistically superior and clinically significant reductions in HbA1c and body weight for up to 2 years compared to placebo and active control treatment (sitagliptin, insulin glargine, exenatide ER and dulaglutide)
It's about your cells getting overloaded trying to process everything
BPC-157 heals more than just the injection site
At least, to us
At follow-up visits conducted 1.5 months later, on average, the researchers found that average BMI for this subgroup was 27.2 kg/m 2 (95% CI, 26.3-28.1), representing a mean total weight reduction of 25.5% (95% CI, 23.1-27.9)
This can include contamination, bad compounding, wrong doses, or sterilization problems in injectable drugs